Findings

What do systematic reviews say?

4,730 questions · 18,059 findings · 1,282 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,360 · 24.1%GRADE not reported 2,529 · 14%Very low 4,641 · 25.7%Low 4,007 · 22.2%Moderate 2,057 · 11.4%High 465 · 2.6%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Bethanechol vs placebo

Post‐void residual urine volume (mL) at 1 month after surgery

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Very low

Bethanechol vs placebo

Urinary tract infection

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bethanechol vs placebo

Subjective urinary symptoms

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Suprapubic catheterisation vs intermittent self‐catheterisation

Rate of spontaneous voiding recovery 1 week after surgery

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Suprapubic catheterisation vs intermittent self‐catheterisation

QoL

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

Health behaviours · adults

1 finding from 1 review

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
no estimate extracted
54 studies · 20139 participants
Low

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

Body function · adults

1 finding from 1 review

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
no estimate extracted
30 studies · 4521 participants
Very low

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · adults

1 finding from 1 review

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 3792 participants
Low

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

Psychological outcomes ‐ Distress and Depression · adults

1 finding from 1 review

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 2070 participants
Low

Summary of findings ‐ Interactive Social Media vs non‐interactive social media

Adverse events · adults

1 finding from 1 review

Behavioural interventions delivered through interactive social media for health behaviour change, health outcomes, and… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Antibiotics vs no treatment

Incidence of HUS · patients with diarrhoea due to Shiga toxin‐producing E. coli

It is very uncertain whether antibiotics changes incidence of HUS compared with no treatment (very low certainty).

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
RR 0.57 [0.11, 2.81]
1 study · 47 participants
Very low

Bovine colostrum vs placebo

Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Synsorb Pk vs placebo

Incidence of HUS · patients with diarrhoea due to Shiga toxin‐producing E. coli

It is very uncertain whether synsorb Pk changes incidence of HUS compared with placebo (very low certainty).

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
RR 0.93 [0.39, 2.22]
1 study · 353 participants
Very low

Synsorb Pk vs placebo

Adverse events · patients with diarrhoea due to Shiga toxin‐producing E. coli

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Synsorb Pk vs placebo

Need for acute dialysis · patients with diarrhoea due to Shiga toxin‐producing E. coli

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Synsorb Pk vs placebo

Neurological complications · patients with diarrhoea due to Shiga toxin‐producing E. coli

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Synsorb Pk vs placebo

Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Urtoxazumab (3.0 mg/kg) vs placebo

Incidence of HUS · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli

It is very uncertain whether urtoxazumab (3.0 mg/kg) changes incidence of HUS compared with placebo (very low certainty).

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
RR 0.34 [0.01, 8.14]
1 study · 71 participants
Very low

Urtoxazumab (3.0 mg/kg) vs placebo

Adverse events ‐ treatment emergent · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli

Urtoxazumab (3.0 mg/kg) showed no clear difference in adverse events ‐ treatment emergent compared with placebo (low certainty).

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
RR 1 [0.84, 1.18]
1 study · 71 participants
Low

Urtoxazumab (3.0 mg/kg) vs placebo

Adverse events ‐ serious · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli

Urtoxazumab (3.0 mg/kg) may leads to lower adverse events ‐ serious compared with placebo (low certainty).

1 finding from 1 review

Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 71 participants
Low